Guardion Health Sciences, Inc.
GHSI · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $3 | $3 | $3 |
| % Growth | -97.6% | 2.2% | -12% | – |
| Cost of Goods Sold | $0 | $2 | $2 | $2 |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 49.8% | 39.3% | 45.8% | 43.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $2 | $2 | $2 |
| SG&A Expenses | $1 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $2 | $2 | $2 |
| Operating Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -1,894.4% | -34% | -23.6% | -23.2% |
| Other Income/Exp. Net | -$1 | -$3 | $2 | $1 |
| Pre-Tax Income | -$2 | -$5 | $0 | $0 |
| Tax Expense | $0 | $0 | $3 | $0 |
| Net Income | $10 | -$5 | $0 | $0 |
| % Margin | 14,158.8% | -158.2% | 14.5% | 11.2% |
| EPS | 8.04 | -3.71 | 0.33 | 0.29 |
| % Growth | 316.7% | -1,224.2% | 13.8% | – |
| EPS Diluted | 8.04 | -3.71 | 0.33 | 0.29 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -1,869.1% | -46.4% | -23.4% | -23% |